NDC 0002-7950
Etesevimab
Etesevimab
Etesevimab is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Etesevimab.
| Product ID | 0002-7950_26bc28c0-e8ff-470f-96c7-db44b1e690ab |
| NDC | 0002-7950 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Etesevimab |
| Generic Name | Etesevimab |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-02-09 |
| Marketing Category | EMERGENCY USE AUTHORIZATION / UNAPPROVED DRUG OTHER |
| Labeler Name | Eli Lilly and Company |
| Substance Name | ETESEVIMAB |
| Active Ingredient Strength | 35 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |